Very interesting study. I had recently read that an ER physician in LA was close to death from Covid19 and when his colleagues treated him with actemra he miraculously recovered. Sounded pretty promising to me so I thank you for the additional info.
Recent RHHBY News
- Genentech Highlights New Breast Cancer and Precision Oncology Data Ahead of ASCO 2026 (RHHBY) • IH Market News • 05/19/2026 02:48:10 PM
- Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition • InvestorsHub NewsWire • 04/22/2026 01:00:00 PM
- Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs) • GlobeNewswire Inc. • 04/09/2026 10:59:00 AM
- /C O R R E C T I O N -- Roche/ • PR Newswire (US) • 03/24/2026 08:05:00 PM
- /C O R R E C T I O N -- Roche/ • PR Newswire (US) • 03/24/2026 07:27:00 PM
- Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets • PR Newswire (US) • 03/24/2026 06:00:00 AM
- Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets • PR Newswire (US) • 03/24/2026 06:00:00 AM
- Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation • PR Newswire (US) • 03/18/2026 01:00:00 PM
- Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease • PR Newswire (US) • 03/16/2026 06:00:00 AM
- Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease • PR Newswire (US) • 03/16/2026 06:00:00 AM
- New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools • PR Newswire (US) • 03/05/2026 06:15:00 AM
- Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development • InvestorsHub NewsWire • 02/19/2026 02:00:00 PM
- Form F-6 POS - Post-effective amendments for immediately effective filing • Edgar (US Regulatory) • 01/28/2026 07:33:05 PM
- Throwing Precision Darts: The Company Leading Next Evolution of Cancer Radiation • AllPennyStocks.com • 01/05/2026 05:38:00 PM
- When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology • AllPennyStocks.com • 12/22/2025 11:45:00 AM
- AstraZeneca Reports Fasenra Misses Primary Endpoint in COPD Study • UK Market News • 09/17/2025 08:28:22 AM
- Stopping Cancer Before It Spreads: The EMT Revolution in Oncology • AllPennyStocks.com • 09/08/2025 12:00:00 PM
- Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • InvestorsHub NewsWire • 07/07/2025 01:00:00 PM
